272 related articles for article (PubMed ID: 31439118)
1. Multidrug-resistant tuberculosis in South Korea: a retrospective analysis of national registry data in 2011-2015.
Lee M; Han J; Kim YR; Kwak N; Kim JH; Park O; Shin S; Moon HS; Kim HJ; Jang MJ; Yim JJ
Int J Tuberc Lung Dis; 2019 Jul; 23(7):850-857. PubMed ID: 31439118
[No Abstract] [Full Text] [Related]
2. Additional Drug Resistance in Patients with Multidrug-resistant Tuberculosis in Korea: a Multicenter Study from 2010 to 2019.
Lee T; Lee SJ; Jeon D; Lee HY; Kim HJ; Kang BH; Mok J
J Korean Med Sci; 2021 Jul; 36(26):e174. PubMed ID: 34227261
[TBL] [Abstract][Full Text] [Related]
3. Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design.
Mok JH; Kang BH; Lee T; Lee HK; Jang HJ; Cho YJ; Jeon D
J Korean Med Sci; 2017 Apr; 32(4):636-641. PubMed ID: 28244290
[TBL] [Abstract][Full Text] [Related]
4. Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial.
Lee M; Mok J; Kim DK; Shim TS; Koh WJ; Jeon D; Lee T; Lee SH; Kim JS; Park JS; Lee JY; Kim SY; Lee JH; Jo KW; Jhun BW; Kang YA; Ahn JH; Kim CK; Shin S; Song T; Shin SJ; Kim YR; Ahn H; Hahn S; Won HJ; Jang JY; Cho SN; Yim JJ
Trials; 2019 Jan; 20(1):57. PubMed ID: 30651149
[TBL] [Abstract][Full Text] [Related]
5. Drug-resistance pattern of Mycobacterium tuberculosis strains from patients with pulmonary and extrapulmonary tuberculosis during 2006 to 2013 in a Korean tertiary medical center.
Lee HY; Lee J; Lee YS; Kim MY; Lee HK; Lee YM; Shin JH; Ko Y
Korean J Intern Med; 2015 May; 30(3):325-34. PubMed ID: 25995663
[TBL] [Abstract][Full Text] [Related]
6. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
[TBL] [Abstract][Full Text] [Related]
7. Extensively drug-resistant tuberculosis in california, 1993-2006.
Banerjee R; Allen J; Westenhouse J; Oh P; Elms W; Desmond E; Nitta A; Royce S; Flood J
Clin Infect Dis; 2008 Aug; 47(4):450-7. PubMed ID: 18616396
[TBL] [Abstract][Full Text] [Related]
8. [Tuberculosis Laboratory Surveillance Network (TuLSA) study group. The first step for national tuberculosis laboratory surveillance: Ankara, 2011].
Sezen F; Albayrak N; Özkara Ş; Karagöz A; Alp A; Duyar Ağca F; İnan Süer A; Müderris T; Ceyhan İ; Durmaz R; Ertek M;
Mikrobiyol Bul; 2015 Apr; 49(2):143-55. PubMed ID: 26167815
[TBL] [Abstract][Full Text] [Related]
9. Second nationwide anti-tuberculosis drug resistance survey in Namibia.
Ruswa N; Mavhunga F; Roscoe JC; Beukes A; Shipiki E; van Gorkom J; Sawadogo S; Agolory S; Menzies H; Tiruneh D; Makumbi B; Bayer B; Zezai A; Campbell P; Alexander H; Kalisvaart N; Forster N
Int J Tuberc Lung Dis; 2019 Jul; 23(7):858-864. PubMed ID: 31439119
[TBL] [Abstract][Full Text] [Related]
10. Increase in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance Survey.
Menzies HJ; Moalosi G; Anisimova V; Gammino V; Sentle C; Bachhuber MA; Bile E; Radisowa K; Kachuwaire O; Basotli J; Maribe T; Makombe R; Shepherd J; Kim B; Samandari T; El-Halabi S; Chirenda J; Cain KP
Int J Tuberc Lung Dis; 2014 Sep; 18(9):1026-33. PubMed ID: 25189548
[TBL] [Abstract][Full Text] [Related]
11. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcomes of multidrug-resistant tuberculosis in Switzerland.
Helbling P; Altpeter E; Egger JM; Zellweger JP
Swiss Med Wkly; 2014; 144():w14053. PubMed ID: 25474040
[TBL] [Abstract][Full Text] [Related]
13. Multidrug and extensively drug-resistant tuberculosis in Canada 1997-2008: demographic and disease characteristics.
Minion J; Gallant V; Wolfe J; Jamieson F; Long R
PLoS One; 2013; 8(1):e53466. PubMed ID: 23326436
[TBL] [Abstract][Full Text] [Related]
14. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.
Holtz TH; Sternberg M; Kammerer S; Laserson KF; Riekstina V; Zarovska E; Skripconoka V; Wells CD; Leimane V
Ann Intern Med; 2006 May; 144(9):650-9. PubMed ID: 16670134
[TBL] [Abstract][Full Text] [Related]
15. Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.
van Altena R; de Vries G; Haar CH; de Lange WC; Magis-Escurra C; van den Hof S; van Soolingen D; Boeree MJ; van der Werf TS
Int J Tuberc Lung Dis; 2015 Apr; 19(4):406-12. PubMed ID: 25859995
[TBL] [Abstract][Full Text] [Related]
16. First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017.
Glasauer S; Altmann D; Hauer B; Brodhun B; Haas W; Perumal N
PLoS One; 2019; 14(6):e0217597. PubMed ID: 31188848
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis in Australia: bacteriologically-confirmed cases and drug resistance, 2011. A report of the Australian Mycobacterium Reference Laboratory Network.
Lumb R; Bastian IB; Jelfs PJ; Keehner TJ; Pandey SK; Sievers A
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E369-75. PubMed ID: 25631600
[TBL] [Abstract][Full Text] [Related]
18. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
[TBL] [Abstract][Full Text] [Related]
20. Multidrug-resistant Mycobacterium tuberculosis: a report of cosmopolitan microbial migration and an analysis of best management practices.
Joean O; Thiele T; Schütz K; Schwerk N; Sedlacek L; Kalsdorf B; Baumann U; Stoll M
BMC Infect Dis; 2020 Sep; 20(1):678. PubMed ID: 32942990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
